infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Services
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 21 articles from: Coronavirus

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Harnessing the COVID-19 Response Towards Hepatitis C Elimination

    Treatment Action Group / 22 February 2021

  • COVID-19 hits viral hepatitis care for vulnerable populations

    The Lancet / 22 February 2021

  • Govt rejects pharma giant Mylan’s proposal to test low-cost hepatitis drug combo against Covid

    The Print / 28 September 2020

  • DCGI Rejects Mylan’s Request to Waive Phase 3 Trials for COVID-19 Drug

    Science Wire / 11 August 2020

  • Care of Patients with Liver Disease during the COVID-19 Pandemic

    EASL / 27 July 2020

  • COVID-19 Toolkit for liver patient associations

    EASL / 27 July 2020

  • What to Know About Liver Disease and COVID-19

    Centers for Disease Control / 09 June 2020

  • COVID-19 triggers innovative collaboration in healthcare services, yet liver patient care suffers setbacks globally

    EASL / 27 May 2020

  • Hepatitis C Drugs May Help Fight COVID-19, Suggests Study

    NDTV / 07 May 2020

  • What does COVID-19 mean for hepatitis C elimination plans in London?

    Drink and Drugs News / 06 May 2020

← First123Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2017. All rights reserved. We are not responsible for the content of external websites.

We are grateful to Abbvie, Janssen, Merck and Gilead for funding infohep.org. Our funders have had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

NAM working with the World Hepatitis Alliance and the European Liver Patients Association

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//   www.worldhepatitisalliance.org   www.elpa-info.org